KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $109,909 | +632.7% | 10,807 | +1840.2% | 0.00% | – |
Q1 2021 | $15,000 | -59.5% | 557 | -75.5% | 0.00% | – |
Q4 2020 | $37,000 | +311.1% | 2,269 | +259.6% | 0.00% | – |
Q3 2020 | $9,000 | -30.8% | 631 | -41.6% | 0.00% | – |
Q2 2020 | $13,000 | -53.6% | 1,081 | -31.5% | 0.00% | – |
Q4 2019 | $28,000 | +133.3% | 1,579 | +54.5% | 0.00% | – |
Q3 2019 | $12,000 | -45.5% | 1,022 | +4.9% | 0.00% | – |
Q2 2019 | $22,000 | -86.7% | 974 | -83.3% | 0.00% | – |
Q1 2019 | $166,000 | +84.4% | 5,824 | +28.5% | 0.00% | – |
Q4 2018 | $90,000 | – | 4,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |